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Finite element methodAbstract Background: The delivery of drugs through dermal layers known as transdermal drug
delivery is one of the important contributions in medical practice. It represents an alternative to oral
drug delivery and is poised to provide a substitute to hypodermic injections too. The diffusion of
drug from the source to the target site is therefore an important issue to address.
Aim: This paper is an attempt to establish a mathematical model for the diffusion of drugs through
the transdermal drug delivery system. The model identiﬁes the pattern of drug diffusion in human
body and its effective absorption rates at various compartments of skin and sub-cutaneous tissues.
Methods: The ﬁnite element method has been used to obtain the solution of the mass diffusion
equation with appropriate boundary conditions. The tissue absorption rate of drug has been taken
as the decreasing function of drug concentration from the skin surface towards the target site. The
concentration at nodal points has been calculated which in turn determines the drug absorption at
various layers.
Conclusion: The drug concentration at the nodal points of different dermal layers has been com-
puted and the graphs were plotted between drug concentration and thickness of dermal layers using
MATLAB software. It has been observed that due to dense network of connective tissues in dermal
and sub-dermal parts, the drug absorption is maximum as compared to cutaneous tissues.
ª 2014 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. All rights
reserved.1. Introduction
In medical sciences, various attempts have been made to search
new drugs and to ﬁnd the improved ways of drug delivery in
the body. Oral drug mechanism delivery like pills has been
considered as one of the most appropriate methods of drug
administration for decades worldwide. There are many drugs
which cannot be taken orally so they are injected into the body
by making use of hypodermic needles. However, the hypoder-
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of pain, the appearance of infections and the requirement for
medical expertise to complete the process.1 For the administra-
tion of drug and its absorption to target the desired compart-
ment of the biological tissue; it is one of the challenging
problems to control the adverse effects of the drug delivery
through in-vivo tissues. Thus, it is desirable to address this
issue by using an appropriate method of drug administration
through dermal regions of the human body with minimal side
effects. Transdermal drug delivery (TDD) is an alternate route
of drug administration to pills and injections. This method
operates by delivery of drugs into the human body across
the skin and subcutaneous layers. TDD system has the ability
to overcome the problems associated with the traditional deliv-
ery of drugs.
Transdermal drug delivery system has been in existence
since last thirty years. Transdermal therapeutic systems are
deﬁned as self contained, continuous dosage forms which when
applied to the skin deliver the drug through it at a controlled
rate to the systemic circulation. TDD is a feasible administra-
tion route for potent and low molecular weight therapeutic
agents. The choice of therapeutic agent is determined by a
number of factors which includes the physio-co-chemical prop-
erties of the drug and its interactions with the membrane. This
is due to the barrier function of the skin represented by the
outer layer- the stratum corneum, which generally allows diffu-
sion of only small molecular weight solutes. To overcome this
diffusion limitation at the stratum corneum, various methods
have been developed to enhance drug delivery across stratum
corneum which includes chemical enhancers or physical enhan-
cer technique e.g. iontophoresis and ultrasound.
The transport of drug through the device and skin follows
the Fickian diffusion process by means of a simple homoge-
neous membrane. Kalia and Guy2 have established the math-
ematical transport models describing the release of drug from
various delivery systems and formulations based on the solu-
tion of Fick’s second law. In these models, skin was simply
treated as a boundary condition and the main attention was
focussed on the drug transport, also analytical expressions
were found for the amount of drug released from the device.
Qaliaf et al.3 developed a mathematical model and carried
numerical simulations to describe the pharmacokinetics of
drug penetration into the skin from microneedle array. Missel4
used FEM for modelling of diffusion and partitioning in bio-
logical systems. One-dimensional mathematical models were
developed by Lee et al.5,6 which considers a single component
drug penetration via both intercellular and transcellular path-
ways of the skin. The skin was divided into stratum corneum
and viable epidermal layers and diffusion of drug from the
porous device into the multiple pathway model of skin was cal-
culated by ﬁnite difference approximations. Saxena, Pardasani
and their co-workers7–9 had carried out a notable research for
the study of heat distribution in biological tissues. Khanday10
studied the temperature distribution in multi-layered human
skin and sub-cutaneous (SST) by assuming the thermal con-
ductivity as a function of temperature. Khanday et al.11–14
studied the diffusion of heat and mass in biological tissues
particularly dermal regions and human head. Sharma and
Saxena15 used FEM to study the drug distribution in TDD A physical process in which ion ﬂow diffusively in a medium driven
by an applied electric ﬁeld.systems in steady state case by making use of quadratic shape
function. Most of the models have taken into consideration
only the drug transport in the devices and did not discuss
the ﬂow of drug in the skin and sub-cutaneous tissues. In this
paper, a variational ﬁnite element approach with linear shape
function is used to obtain the solution of diffusion equation
taking into account the role of diffusion constant and the rate
constants. The method has been used because of its applicabil-
ity over the irregular geometries. Since the human skin has
irregular geometry, therefore this method guarantees a reason-
able outcome as compared to the other numerical methods.2. Formulation of model
The transport of drugs through transdermal system is gov-
erned by the differential equation given in Crank16
@
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where C;Dand t denote the drug concentration, mass diffusiv-
ity and time. Also, AðCÞ is the absorption rate of drug by the
tissues, which is a function of concentration and B is the rate of
drug intake by the blood.
Consider the domain consisting of three layers viz., epider-
mis, dermis and subcutaneous region with outer and inner
boundaries as a0 and a3. The concentration of the drug at
the outer skin surface (epidermis) is known as C0 and it has
negligible concentration beyond the subcutaneous tissue as
the drug is absorbed through the subcutaneous tissue to reach
the target site. Hence at the innermost boundary the concen-
tration is C3 ¼ 0.
By the law of mass action, the absorption rate of drug by
the tissue decreases with changing time, so we can say that
absorption rate is decreasing function of drug concentration.
Hence, we assume
AiðCðiÞÞ ¼ expðkiCðiÞÞ; ði ¼ 1; 2; 3Þ ð2Þ
where kið 1Þ represents the rate constants. The drug distribu-
tion has a mild barrier at the interfaces due to non-homoge-
neous character of tissues in various layers of dermal
regions. So,
CðiÞ ¼ qiCðiþ1Þjx¼aiði¼1;2Þ ð3Þ
Here xandqi ði ¼ 1; 2Þ represents the depth below the skin
surface and the skin partition coefﬁcients for the drug at the
respective interfaces respectively. qi  1 for most of the
drugs17.
The solution CðxÞ of the problem can be approximated by
polynomial functions of x of higher degrees. Since the distance
between the skin layers is of minute length, the higher order
shape functions may not contribute a signiﬁcant change in
the drug diffusion, therefore the concentration of drug in each
region is approximated by a linear polynomial as
CðiÞ ¼ /i þ uix; ði ¼ 1; 2; 3Þ ð4Þ3. Mathematical method
The solution of such type of problem has been carried out by
various researchers. The numerical solution of the boundary
 Let F ðsÞandGðsÞ be two polynomials in s where the degree of F ðsÞ is
lower than that of GðsÞ and if GðsÞ has n distinct roots
ai ði ¼ 1; 2; . . . ; nÞ, then
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Variational ﬁnite element method to study the absorption rate of drug 221value problem is important for various situations due to the
non-availability of the analytical and exact solutions. But,
the ﬁnite element method is treated to be one of the most reli-
able methods in numerical systems. The method has advantage
over other methods due to position dependent properties of
parameters and their ﬂexibility. Moreover, the method is appli-
cable to understand the feasible diffusion in irregular geome-
tries. The variational integral
I ¼
Z
FðC;C0; xÞdx ð5Þ
in optimum form is equivalent to Euler-Lagrange differential
equation given by Myer18
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On comparing Eq. (1) with Euler-Lagrange Eq. (6), we obtain
the variational integral
I ¼
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The variational integral on each of the sub domains are given
as
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Now, these integrals Ii are assembled to obtain I ¼
P3
i¼1Ii
and I is optimised with respect to the nodal values
Ci ði ¼ 1; 2Þ to get the system of equations
a1C1 þ a2C2 þ b1 _C1 þ b2 _C2 ¼ c1 ð10Þ
a2C1 þ a3C2 þ b2 _C1 þ b3 _C2 ¼ c2 ð11Þ
where the coefﬁcients are given in the Appendix.
The Eqs. (10) and (11) in the matrix form can be written as
ACþ B _C ¼ Y
where A ¼ a1 a2
a2 a3
 
; B ¼ b1 b2
b2 b3
 
and Y ¼ c1
c2
 
; C ¼ C1
C2
  ð12Þ
Case:I (Steady State)
Solving equation AC ¼ Y, we get the values of the concen-
tration of the drug at the nodes a1 anda2 as C1ða1; 0Þand
C2ða2; 0Þ which in turn on substitution to Eq. (4) are used to
determine the values of CðiÞ ði ¼ 1; 2; 3Þ.Case:II (Unsteady State)
Applying the Laplace transform to the Eq. (12), we have
L ACþ B _C  ¼LðYÞ
or; ALðCÞ þ B sLðCÞ  Cðx; 0Þð Þ ¼LðYÞ
i:e:; ðAþ BsÞLðCÞ ¼LðYÞ þ BCðx; 0Þ
which gives ða1 þ b1sÞ bC1 þ ða2 þ b2sÞ bC2 ¼ c1s þ b1C1ða1; 0Þ
þ b2C2ða2; 0Þ ð13Þ
and ða2 þ b2sÞ bC1 þ ða3 þ b3sÞ bC2 ¼ c2s þ b2C1ða1; 0Þ
þ b3C2ða2; 0Þ ð14Þ
where ˆ represents Laplace transform.
On solving Eqs. (13) and (14), we have
bC1 ¼ ða3 þ sb3Þðm1 þ c1s Þ  ða2 þ sb2Þðm2 þ c2s Þðs aÞðs bÞ ð15Þ
and bC2 ¼ ða1 þ sb1Þðm2 þ c2s Þ  ða2 þ sb2Þðm1 þ c1s Þðs aÞðs bÞ ð16Þ
Applying the inverse Laplace transform and making use of
Heaviside Expansion theorem, we get the value of Ci ði ¼ 1; 2Þ
which on substitution to Eq. (4) is used to determine the value
of CðiÞ ði ¼ 1; 2; 3Þ at any instant of time. The overall drug con-
centration can be formulated by assembling the linear varia-
tions of each region. This indicates polygonal variations of
concentration with discontinuities of ﬂux at the interfaces. In
order to obtain the better approximations, the Lagrange’s
interpolation method has been used. The method determines
the drug concentration with continuous ﬂux between the inter-
faces and within the region.
CðxÞ ¼ H0x3 H1x2 þH2xH3 ð17Þ4. Numerical calculations
To solve Eq. (12), we make use of the values given in Sharma
and Saxena15 of the constants given in the Table 1.
We can assign different values to the constants
ai ði ¼ 0; 1; 2; 3Þ and Di ði ¼ 1; 2; 3Þ depending on the sample
of the skin under study. The set of values considered here are
a0 ¼ 0 lm; a1 ¼ 0:3 lm; a2 ¼ 0:6 lm; a3 ¼ 1 lm
D1 ¼ 0:00068 lm2 s1;D2 ¼ 0:0205 lm2 s1;D3 ¼ 0:002 lm2 s1
The numerical calculations have been carried out for 5 grams
of drug. The curves have been plotted for CðiÞði ¼ 1; 2; 3Þ versus
thickness of skin layers at time t ¼ 0; 5 and 10 sec. The proﬁles
of drug concentration in two different set of values are shown
in Figs. 1 and 2.
Table 1 Numerical values.
q1 q2 B2 ðlm3Þ B3 k1 ðsec1Þ k2 k3
Set-I 0.8 0.9 0.002 0.02 0.4 0.5 0.55
Set-II 0.98 1 0.1 0.2 0.5 0.7 0.8
Figure 1 Concentration proﬁle for Set-I at t ¼ 0; 5 and 10 sec.
Figure 2 Concentration proﬁle for Set-II at t ¼ 0; 5 and 10 sec.
Figure 3 Modiﬁed drug concentration based on Lagrange’s
interpolation method for Set-I.
Figure 4 Modiﬁed drug concentration based on Lagrange’s
interpolation method for Set-II.
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The present work is an attempt to estimate the drug concentra-
tion in the human dermal layers. Initially, we have calculated
the drug concentration at the nodal points of different dermal
layers and graphs have been plotted using MATLAB software
between concentration and thickness of dermal layers. From
the graphs given in Figs. 1 and 2, the drug concentration
proﬁles at different time intervals have been estimated. It has
been observed that the curves for CðiÞði ¼ 1; 2; 3Þ fall more
quickly in Set-II and reach the equilibrium state earlier than
the Set-I. Analysing the concentration proﬁles, it seems that
the concentration decreases with increase in the partition
coefﬁcient, absorption coefﬁcients and rate constants. Thecurves given in ﬁgures reﬂect the amount of drug absorption
in the region of papillary and reticular layers due to dense
network of capillary bed.
Lagrange’s interpolation formula has been used and the
curve describing the continuous distribution of drug inside
the dermal layers has been obtained and is given in Figs. 3
and 4. The results obtained in this paper appear to be realistic
and are stronger than the results obtained by Sharma and
Saxena15. They had taken the rate of absorption of drug by
the tissues and rate of drug intake by blood as constants while
as in our model, keeping the physiological aspects of the der-
mal layers into consideration, the absorption rate has been
taken as an exponentially decreasing function of the concen-
Variational ﬁnite element method to study the absorption rate of drug 223tration. Also they have studied the drug distribution in TDD
systems for steady state case while the present work is time
dependent problem and therefore their model is a special case
of our model. Our work shows a close resemblance and gives
modiﬁed outcome than the work carried out by Sharma and
Saxena15 for steady state case. Moreover, our model is time
dependent and the time plays a key role in drug diffusion.
The developed model helps us in predicting the amount of
the drug concentration in different tissues at different time
intervals. Also, this model may be helpful in analysing the role
of the diffusion constants and the absorption coefﬁcients in
drug delivery system. The study may be very helpful in the
medical sciences in various situations.
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Appendix A.
hi ¼ aiþ1  ai; ði ¼ 0; 1; 2:Þ; gi ¼
Di
hi
;
ri ¼ kihi; ði ¼ 1; 2; 3Þ
qj ¼
gj
q2j1
; nj ¼ rjq2j1
; pj ¼
hj
q2j1
; ðj ¼ 2; 3Þ
a1 ¼ 2 g1 þ q2ð Þ 
2
3
r1 þ n2ð Þ; a2 ¼ 1q1
2g2 þ
r2
3

 
a3 ¼ 2 g2 þ q3ð Þ 
2
3
r2 þ n3ð Þ; b1 ¼
2
3
h1 þ p2ð Þ;
b2 ¼
q1p2
3q1
b3 ¼ 2 q1b2 þ
p3
3

 
; c1 ¼ 2g1 þ
r1
3

 
c1 ¼ 2g1 þ
p3
3
;
c2 ¼
n3
3
þ 2q3

 
q2C3  ð1þ B2Þh2  ð1þ B3Þp3q2
mi ¼ biC1ða1; 0Þ þ biþ1C2ða2; 0Þ; ði ¼ 1; 2Þ
H0 ¼
X3
i¼0
Ci
Di
; Di ¼ P3i–j
j¼0
ðai  ajÞ; ði ¼ 0; 1; 2; 3Þ
H1 ¼
X3
i¼0Hi1
Ci
Di
; Hi1 ¼
X3
j¼0
j–i
aj; ði ¼ 0; 1; 2; 3Þ
H2 ¼
X3
i¼0Hi2
Ci
Di
; H02 ¼ a1a2 þ a1a3 þ a2a3;
H12 ¼ a0a2 þ a0a3 þ a2a3
H22 ¼ a0a1 þ a0a3 þ a1a3; H32 ¼ a0a1 þ a0a2 þ a2a3
H3 ¼
X3
i¼0Hi3
Ci
Di
; Hi3 ¼ P3j¼0
i–j
aj; ði ¼ 0; 1; 2; 3ÞReferences
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